ConductScience.org, home

Paper23737751

Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay.

Laird GM and 7 others. PLoS Pathog, 2013. Cited by 222 papers, by iCite.

Cite this record

ConductScience Library. Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay. Papers, record 23737751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23737751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay.
PubMed
Journal
PLoS Pathog
PubMed
Year
2013
PubMed
Publication types
Clinical Trial, Journal Article, Multicenter Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
222
iCite
Relative citation ratio, by iCite
5.93
iCite
Revised in PubMed
2022-03-09
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Laird GMGregory M
2Eisele EEEvelyn E
3Rabi SAS Alireza
4Lai JJun
5Chioma SStanley
6Blankson JNJoel N
7Siliciano JDJanet D
8Siliciano RFRobert F

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acquired Immunodeficiency SyndromeMajor topic
CD4-Positive T-LymphocytesMajor topic
HIV-1Major topic
RNA, ViralMajor topic
Viral LoadMajor topic
Cohort Studies
Female
Humans
Male
Reverse Transcriptase Polymerase Chain Reaction

Source PubMed

Download CSV of topics

Grants8

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 AI094189NIAID NIH HHSUnited StatesP30AI094189PubMed and NIHNIH RePORTER
U19 AI096109NIAID NIH HHSUnited StatesU19AI096109PubMed and NIHNIH RePORTER
Howard Hughes Medical InstituteUnited StatesPubMedPubMed
43222PHS HHSUnited StatesPubMedPubMed
U19 AI096113NIAID NIH HHSUnited StatesU19AI096113PubMed and NIHNIH RePORTER
AI096113NIAID NIH HHSUnited StatesU19AI096113PubMed and NIHNIH RePORTER
1U19AI096109NIAID NIH HHSUnited StatesU19AI096109PubMed and NIHNIH RePORTER
T32 AI007247NIAID NIH HHSUnited StatesT32AI007247PubMed and NIHNIH RePORTER

Download CSV of grants

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111069234Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection.J Infect Dis2000https://conductscience.org/library/papers/11069234PubMed
212134017Effects of prostratin on T-cell activation and human immunodeficiency virus latency.J Virol2002https://conductscience.org/library/papers/12134017PubMed
321471244Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation.J Virol2011https://conductscience.org/library/papers/21471244PubMed
44567231Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.J Natl Cancer Inst1972https://conductscience.org/library/papers/4567231PubMed
512368337A sensitive, quantitative assay for human immunodeficiency virus type 1 integration.J Virol2002https://conductscience.org/library/papers/12368337PubMed
614532178New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma.J Clin Microbiol2003https://conductscience.org/library/papers/14532178PubMed
712805437Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo.J Virol2003https://conductscience.org/library/papers/12805437PubMed
823270785Targeting HIV latency: pharmacologic strategies toward eradication.Drug Discov Today2013https://conductscience.org/library/papers/23270785PubMed
99287228Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.N Engl J Med1997https://conductscience.org/library/papers/9287228PubMed
109360927Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.Science1997https://conductscience.org/library/papers/9360927PubMed
11159862Human myeloma cells and their strong stimulating capacity in 'one-way' mixed lymphocyte reaction: a comparative study with leukaemic B lymphoid cells.Immunology1979https://conductscience.org/library/papers/159862PubMed
127489410In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency.Nat Med1995https://conductscience.org/library/papers/7489410PubMed
1310229227Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.Nat Med1999https://conductscience.org/library/papers/10229227PubMed
1423459007Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies.PLoS Pathog2013https://conductscience.org/library/papers/23459007PubMed
159287227
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
N Engl J Med1997https://conductscience.org/library/papers/9287227PubMed
169360926Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.Science1997https://conductscience.org/library/papers/9360926PubMed
1719136668Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells.J Biol Chem2009https://conductscience.org/library/papers/19136668PubMed
1822406268Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation.Immunity2012https://conductscience.org/library/papers/22406268PubMed
1916061962Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals.Methods Mol Biol2005https://conductscience.org/library/papers/16061962PubMed
204273215A unique 'leukaemic' T lymphoid cell line: absence of stimulating effect in mixed lymphocyte reaction. Lack of MLR-S in leukaemic T lymphoid cells.Clin Exp Immunol1973https://conductscience.org/library/papers/4273215PubMed

See all 38 referencesDownload CSV of references

Cited by182

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 222 citations.

PMIDTitleJournalYearIn PapersSource
42327144Antigen Stimulation Reactivates HIV-1 Proviruses Despite Integration in Repressive Chromatin.bioRxiv2026https://conductscience.org/library/papers/42327144PubMed
41776101Autologous neutralizing antibodies and polyfunctional T cells contribute to long-term HIV-1 post-intervention control.Nat Immunol2026https://conductscience.org/library/papers/41776101PubMed
41600872Tools to Quantify and Characterize the Persistent Reservoir in People with HIV-1: Focus on Non-B Subtypes.Viruses2026https://conductscience.org/library/papers/41600872PubMed
41600811Development of an Ultrasensitive ELISA Assay for Evaluating HIV-1 Envelope Glycoprotein as a Marker for Targeted Activator of Cell Kill.Viruses2025https://conductscience.org/library/papers/41600811PubMed
41221300The promise and perils of humanized mice: workshop report from the 29th scientific conference of the society on NeuroImmune pharmacology (SNIP).NeuroImmune Pharm Ther2025https://conductscience.org/library/papers/41221300PubMed
40802737Proviruses in CD4+ T cells reactive to autologous antigens contribute to nonsuppressible HIV-1 viremia.Sci Transl Med2025https://conductscience.org/library/papers/40802737PubMed
40741400Flow Cytometric Quantification of HIV-1-Infected Cells Expressing Either Abortive or Elongated HIV-1 Transcripts Using Flow-FISH.Bio Protoc2025https://conductscience.org/library/papers/40741400PubMed
40655347HIV Cure: How Far We Have Come?Indian J Microbiol2025https://conductscience.org/library/papers/40655347PubMed
39859395An Immunocytochemistry Method to Investigate the Translationally Active HIV Reservoir.Int J Mol Sci2025https://conductscience.org/library/papers/39859395PubMed
39835119Current methods for detecting and assessing HIV-1 antibody resistance.Front Immunol2024https://conductscience.org/library/papers/39835119PubMed
39401241Isotretinoin promotes elimination of translation-competent HIV latent reservoirs in CD4T cells.PLoS Pathog2024https://conductscience.org/library/papers/39401241PubMed
38978287Extracellular vesicle isolation methods identify distinct HIV-1 particles released from chronically infected T-cells.J Extracell Vesicles2024https://conductscience.org/library/papers/38978287PubMed
38485563Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regimen.EBioMedicine2024https://conductscience.org/library/papers/38485563PubMed
38400005A Canadian Survey of Research on HIV-1 Latency-Where Are We Now and Where Are We Heading?Viruses2024https://conductscience.org/library/papers/38400005PubMed
38278966Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells.Nat Immunol2024https://conductscience.org/library/papers/38278966PubMed
38026212Understanding latent HIV-1 reservoirs through host genomics approaches.iScience2023https://conductscience.org/library/papers/38026212PubMed
37957382Viral and host mediators of non-suppressible HIV-1 viremia.Nat Med2023https://conductscience.org/library/papers/37957382PubMed
37698927Proviral location affects cognate peptide-induced virus production and immune recognition of HIV-1-infected T cell clones.J Clin Invest2023https://conductscience.org/library/papers/37698927PubMed
37665978Measuring Human Immunodeficiency Virus Reservoirs: Do We Need to Choose Between Quantity and Quality?J Infect Dis2024https://conductscience.org/library/papers/37665978PubMed
37463049The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy.J Clin Invest2023https://conductscience.org/library/papers/37463049PubMed

See all 182 cited byDownload CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23737751

GET https://conductscience.org/api/papers/v1/23737751/references?page=2